Statistics
Publications
3
Citations
1.1K
H-Index
3
Active since
2018
Ricardo Dolmetsch is an author at Novartis (Switzerland) specializing in stem cell differentiation, crispr-cas systems, and crispr-based engineering.
Publications per year
2018–2024
3
3
p53 inhibits CRISPR–Cas9 engineering in human pluripotent stem cells
Robert J. Ihry, Kathleen A. Worringer, Max R. Salick et al. · Nature Medicine · 2018 · 1K citations
Genome-Scale CRISPR Screens Identify Human Pluripotency-Specific Genes
Robert J. Ihry, Max R. Salick, Daniel Ho et al. · Cell Reports · 2019 · 80 citations · Full text
1–3 of 3